912 related articles for article (PubMed ID: 21316532)
1. A review of the treatment of chronic hepatitis C virus infection in cirrhosis.
Vezali E; Aghemo A; Colombo M
Clin Ther; 2010 Dec; 32(13):2117-38. PubMed ID: 21316532
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.
Martín-Carbonero L; Tuma P; Vispo E; Medrano J; Labarga P; González-Lahoz J; Barreiro P; Soriano V
J Viral Hepat; 2011 Aug; 18(8):542-8. PubMed ID: 20819149
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection].
Cheong HR; Woo HY; Heo J; Yoon KT; Kim DU; Kim GH; Kang DH; Song GA; Cho M
Korean J Hepatol; 2010 Mar; 16(1):38-48. PubMed ID: 20375641
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
[TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection.
Iacobellis A; Andriulli A
Expert Opin Pharmacother; 2009 Aug; 10(12):1929-38. PubMed ID: 19563272
[TBL] [Abstract][Full Text] [Related]
6. A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials.
Zhao S; Liu E; Chen P; Cheng D; Lu S; Yu Q; Wang Y; Wei K; Yang P
Clin Ther; 2010 Aug; 32(9):1565-77. PubMed ID: 20974315
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis.
Iacobellis A; Perri F; Valvano MR; Caruso N; Niro GA; Andriulli A
Clin Gastroenterol Hepatol; 2011 Mar; 9(3):249-53. PubMed ID: 21092761
[TBL] [Abstract][Full Text] [Related]
8. Pegylated interferon alpha-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases.
Iacob S; Gheorghe L; Hrehoret D; Becheanu G; Herlea V; Popescu I
J Gastrointestin Liver Dis; 2008 Jun; 17(2):165-72. PubMed ID: 18568137
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation.
Ponziani FR; Annicchiarico EB; Siciliano M; D'Aversa F; Pompili M; Gasbarrini A
World J Gastroenterol; 2013 Jun; 19(21):3255-62. PubMed ID: 23745027
[TBL] [Abstract][Full Text] [Related]
10. Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy.
Giannini EG; Afdhal NH; Sigal SH; Muir AJ; Reddy KR; Vijayaraghavan S; Elkashab M; Romero-Gómez M; Dusheiko GM; Iyengar M; Vasey SY; Campbell FM; Theodore D
J Gastroenterol Hepatol; 2015 Aug; 30(8):1301-8. PubMed ID: 25777337
[TBL] [Abstract][Full Text] [Related]
11. Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C.
Jung CH; Um SH; Kim TH; Yim SY; Suh SJ; Yim HJ; Seo YS; Choi HS; Chun HJ
Gut Liver; 2016 Sep; 10(5):808-17. PubMed ID: 27114417
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials.
Vierling JM; Zeuzem S; Poordad F; Bronowicki JP; Manns MP; Bacon BR; Esteban R; Flamm SL; Kwo PY; Pedicone LD; Deng W; Dutko FJ; DiNubile MJ; Koury KJ; Helmond FA; Wahl J; Bruno S
J Hepatol; 2014 Aug; 61(2):200-9. PubMed ID: 24747798
[TBL] [Abstract][Full Text] [Related]
13. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
14. Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series.
Mukherjee S; Lyden E
Hepatogastroenterology; 2006; 53(70):561-5. PubMed ID: 16995462
[TBL] [Abstract][Full Text] [Related]
15. Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis.
Syed E; Rahbin N; Weiland O; Carlsson T; Oksanen A; Birk M; Davidsdottir L; Hagen K; Hultcrantz R; Aleman S
Scand J Gastroenterol; 2008; 43(11):1378-86. PubMed ID: 18615358
[TBL] [Abstract][Full Text] [Related]
16. Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C.
Aghemo A; Rumi MG; Colombo M
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):925-35. PubMed ID: 19803700
[TBL] [Abstract][Full Text] [Related]
17. Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis.
Floreani A; Baldo V; Rizzotto ER; Carderi I; Baldovin T; Minola E
J Clin Gastroenterol; 2008 Jul; 42(6):734-7. PubMed ID: 18285717
[TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis.
Roffi L; Colloredo G; Pioltelli P; Bellati G; Pozzpi M; Parravicini P; Bellia V; Del Poggio P; Fornaciari G; Ceriani R; Ramella G; Corradi C; Rossini A; Bruno S;
Antivir Ther; 2008; 13(5):663-73. PubMed ID: 18771050
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic hepatitis C in patients with decompensated cirrhosis.
Everson GT
Rev Gastroenterol Disord; 2004; 4 Suppl 1():S31-8. PubMed ID: 15184823
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
